210 related articles for article (PubMed ID: 30796656)
1. Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis.
Rice SR; Feigenberg SJ; Hamza M; Molitoris JK; Bentzen SM; Tkaczuk KHR; Rosenblatt PM; Bellavance EC; Nichols EM
Breast Cancer Res Treat; 2019 Jun; 175(2):473-478. PubMed ID: 30796656
[TBL] [Abstract][Full Text] [Related]
2. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
3. Omission of radiation therapy following breast conservation in older (≥70 years) women with T1-2N0 triple-negative breast cancer.
Haque W; Verma V; Hsiao KY; Hatch S; Arentz C; Szeja S; Schwartz M; Niravath P; Bonefas E; Miltenburg D; Brian Butler E; Teh BS
Breast J; 2019 Nov; 25(6):1126-1133. PubMed ID: 31273872
[TBL] [Abstract][Full Text] [Related]
4. Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis.
Diwanji TP; Molitoris JK; Chhabra AM; Snider JW; Bentzen SM; Tkaczuk KH; Rosenblatt PY; Kesmodel SB; Bellavance EC; Cohen RJ; Cheston SB; Nichols EM; Feigenberg SJ
Breast Cancer Res Treat; 2017 Sep; 165(2):445-453. PubMed ID: 28639030
[TBL] [Abstract][Full Text] [Related]
5. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
[TBL] [Abstract][Full Text] [Related]
6. Clinical Pathways: A Catalyst for the Adoption of Hypofractionation for Early-Stage Breast Cancer.
Chapman BV; Rajagopalan MS; Heron DE; Flickinger JC; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):854-61. PubMed ID: 26530754
[TBL] [Abstract][Full Text] [Related]
7. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
8. Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States.
Hasan Y; Waller J; Yao K; Chmura SJ; Huo D
Breast Cancer Res Treat; 2017 Apr; 162(2):317-328. PubMed ID: 28120272
[TBL] [Abstract][Full Text] [Related]
9. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
Kang MM; Hasan Y; Waller J; Saulsberry L; Huo D
Clin Breast Cancer; 2022 Jan; 22(1):e8-e20. PubMed ID: 34257001
[TBL] [Abstract][Full Text] [Related]
10. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.
Chan EK; Tabarsi N; Tyldesley S; Khan M; Woods R; Speers C; Weir L
Am J Clin Oncol; 2016 Oct; 39(5):473-8. PubMed ID: 24824143
[TBL] [Abstract][Full Text] [Related]
12. Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer center network.
Rajagopalan MS; Flickinger JC; Heron DE; Beriwal S
Pract Radiat Oncol; 2015; 5(2):63-9. PubMed ID: 25748004
[TBL] [Abstract][Full Text] [Related]
13. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K
Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
[TBL] [Abstract][Full Text] [Related]
15. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study.
Meattini I; Poortmans P; Kirova Y; Saieva C; Visani L; Salvestrini V; Kim J; Jung W; Olmetto E; Mariotti M; Desideri I; Fourquet A; Livi L; Kim K
Acta Oncol; 2020 Feb; 59(2):188-195. PubMed ID: 31760849
[No Abstract] [Full Text] [Related]
17. Hypofractionated radiation treatment in the management of breast cancer.
Gupta A; Ohri N; Haffty BG
Expert Rev Anticancer Ther; 2018 Aug; 18(8):793-803. PubMed ID: 29902386
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
19. Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
Sayan M; Vergalasova I; Jhawar S; Kumar S; George M; Kowzun M; Potdevin L; Toppmeyer D; Haffty B; Ohri N
Clin Breast Cancer; 2021 Feb; 21(1):31-36. PubMed ID: 32792224
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes.
Chan EK; Woods R; McBride ML; Virani S; Nichol A; Speers C; Wai ES; Tyldesley S
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):786-92. PubMed ID: 24606848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
